Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 7317251, 9 pages
https://doi.org/10.1155/2017/7317251
Research Article

Blood-Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism

1Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
2Section on Comparative Medicine, Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
3Section on Gerontology and Geriatrics, Sticht Center for Healthy Aging and Alzheimer’s Prevention & Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
4Department of Pathology, University of Washington, Seattle, WA, USA
5Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA

Correspondence should be addressed to Anthony J. A. Molina; ude.htlaehekaw@aniloma

Received 30 March 2017; Revised 9 June 2017; Accepted 20 July 2017; Published 2 October 2017

Academic Editor: Maik Hüttemann

Copyright © 2017 Daniel J. Tyrrell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Shi, K. Guo, D. T. Yew et al., “Effects of ageing and Alzheimer’s disease on mitochondrial function of human platelets,” Experimental Gerontology, vol. 43, no. 6, pp. 589–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Avila, R. J. Huang, M. V. Stevens et al., “Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins,” Experimental and Clinical Endocrinology & Diabetes, vol. 120, no. 4, pp. 248–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Japiassu, A. P. Santiago, J. C. d'Avila et al., “Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity,” Critical Care Medicine, vol. 39, no. 5, pp. 1056–1063, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Hartman, O. S. Shirihai, M. Holbrook et al., “Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus,” Vascular Medicine, vol. 19, no. 1, pp. 67–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Widlansky, J. Wang, S. M. Shenouda et al., “Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes,” Translational Research, vol. 156, no. 1, pp. 15–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Cordero, M. F. A. M. de MM, I. M. Carmona Lopez et al., “Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease,” Arthritis Research & Therapy, vol. 12, no. 1, article R17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Tyrrell, M. S. Bharadwaj, C. G. Van Horn, S. B. Kritchevsky, B. J. Nicklas, and A. J. Molina, “Respirometric profiling of muscle mitochondria and blood cells are associated with differences in gait speed among community-dwelling older adults,” The Journals of Gerontology Series A, Biological Sciences and Medical Sciences, vol. 70, no. 11, pp. 1394–1399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Tyrrell, M. S. Bharadwaj, C. G. Van Horn, A. P. Marsh, B. J. Nicklas, and A. J. Molina, “Blood-cell bioenergetics are associated with physical function and inflammation in overweight/obese older adults,” Experimental Gerontology, vol. 70, pp. 84–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Tyrrell, M. S. Bharadwaj, M. J. Jorgensen, T. C. Register, and A. J. Molina, “Blood cell respirometry is associated with skeletal and cardiac muscle bioenergetics: implications for a minimally invasive biomarker of mitochondrial health,” Redox Biology, vol. 10, pp. 65–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. B. K. Chacko, P. A. Kramer, S. Ravi et al., “The bioenergetic health index: a new concept in mitochondrial translational research,” Clinical Science, vol. 127, no. 6, pp. 367–373, 2014. View at Google Scholar
  11. D. D. Clarke and L. Sokoloff, “Circulation and energy metabolism of the brain,” Basic neurochemistry: molecular, cellular and medical aspects, vol. 6, pp. 637–669, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Berg, J. L. Tymoczko, and L. Stryer, Each Organ has a Unique Metabolic Profile, W H Freeman, New York, NY, USA, 2002.
  13. R. H. Swerdlow and S. M. Khan, “A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease,” Medical Hypotheses, vol. 63, no. 1, pp. 8–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. G. E. Gibson and Q. Shi, “A mitocentric view of Alzheimer’s disease suggests multi-faceted treatments,” Journal of Alzheimer's Disease, vol. 20, Supplement 2, pp. S591–S607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Cardoso, I. Santana, R. H. Swerdlow, and C. R. Oliveira, “Mitochondria dysfunction of Alzheimer’s disease cybrids enhances Aβ toxicity,” Journal of Neurochemistry, vol. 89, no. 6, pp. 1417–1426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Galindo, I. Ikuta, X. Zhu, G. Casadesus, and J. Jordán, “Mitochondrial biology in Alzheimer’s disease pathogenesis,” Journal of Neurochemistry, vol. 114, no. 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. P. H. Reddy and M. F. Beal, “Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease,” Trends in Molecular Medicine, vol. 14, no. 2, pp. 45–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. H. M. Wilkins and R. H. Swerdlow, “Amyloid precursor protein processing and bioenergetics,” Brain Research Bulletin, vol. 133, pp. 71–79, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada, “Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction,” The Journal of Neuroscience, vol. 26, no. 35, pp. 9057–9068, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Dragicevic, M. Mamcarz, Y. Zhu et al., “Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer’s transgenic mice,” Journal of Alzheimer's Disease, vol. 20, Supplement 2, pp. S535–S550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Du, L. Guo, S. Yan, A. A. Sosunov, G. M. McKhann, and Y. S. ShiDu, “Early deficits in synaptic mitochondria in an Alzheimer’s disease mouse model,” Proceedings of the National Academy of Sciences, vol. 107, no. 43, pp. 18670–18675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Caspersen, N. Wang, J. Yao et al., “Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer’s disease,” The FASEB Journal, vol. 19, no. 14, pp. 2040-2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. A. Hansson Petersen, N. Alikhani, H. Behbahani et al., “The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145–13150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Manczak, T. S. Anekonda, E. Henson, B. S. Park, J. Quinn, and P. H. Reddy, “Mitochondria are a direct site of a beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression,” Human Molecular Genetics, vol. 15, no. 9, pp. 1437–1449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Mosconi, R. Mistur, R. Switalski et al., “FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 5, pp. 811–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Minoshima, B. Giordani, S. Berent, K. A. Frey, N. L. Foster, and D. E. Kuhl, “Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease,” Annals of Neurology, vol. 42, no. 1, pp. 85–94, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Marcus, E. Mena, and R. M. Subramaniam, “Brain PET in the diagnosis of Alzheimer’s disease,” Clinical Nuclear Medicine, vol. 39, no. 10, pp. e413–e422, 2014. View at Publisher · View at Google Scholar
  28. L. M. Bloudek, D. E. Spackman, M. Blankenburg, and S. D. Sullivan, “Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer’s disease,” Journal of Alzheimer's Disease, vol. 26, no. 4, pp. 627–645, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Lunnon, Z. Ibrahim, P. Proitsi et al., “Mitochondrial dysfunction and immune activation are detectable in early Alzheimer’s disease blood,” Journal of Alzheimer's Disease, vol. 30, no. 3, pp. 685–710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Leuner, J. Pantel, C. Frey et al., “Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer’s disease,” Journal of Neural Transmission. Supplementa, vol. 72, pp. 207–215, 2007. View at Publisher · View at Google Scholar
  31. E. Kadioglu, S. Sardas, S. Aslan, E. Isik, and K. A. Esat, “Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer’s disease,” Biomarkers, vol. 9, no. 2, pp. 203–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Mecocci, M. C. Polidori, T. Ingegni et al., “Oxidative damage to DNA in lymphocytes from AD patients,” Neurology, vol. 51, no. 4, pp. 1014–1017, 1998. View at Publisher · View at Google Scholar
  33. J. Valla, L. Schneider, T. Niedzielko et al., “Impaired platelet mitochondrial activity in Alzheimer’s disease and mild cognitive impairment,” Mitochondrion, vol. 6, no. 6, pp. 323–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Fišar, J. Hroudová, H. Hansíková et al., “Mitochondrial respiration in the platelets of patients with Alzheimer’s disease,” Current Alzheimer research, vol. 13, no. 8, pp. 930–941, 2016. View at Publisher · View at Google Scholar
  35. B. Borroni, D. Perani, M. Broli et al., “Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis,” Journal of Neurology, vol. 252, no. 11, pp. 1359–1362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Colciaghi, B. Borroni, L. Pastorino et al., “[alpha]-secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients,” Molecular medicine (Cambridge, Mass), vol. 8, no. 2, pp. 67–74, 2002. View at Google Scholar
  37. P. E. Coskun, J. Wyrembak, O. Derbereva et al., “Systemic mitochondrial dysfunction and the etiology of Alzheimer’s disease and Down syndrome dementia,” Journal of Alzheimer's Disease, vol. 20, Supplement 2, pp. S293–S310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. B. K. Chacko, P. A. Kramer, S. Ravi et al., “The bioenergetic health index: a new concept in mitochondrial translational research,” Clinical Science (London, England), vol. 127, no. 6, pp. 367–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. D. J. Tyrrell, M. S. Bharadwaj, M. J. Jorgensen, T. C. Register, and A. J. Molina, “Blood cell respirometry is associated with skeletal and cardiac muscle bioenergetics: implications for a minimally invasive biomarker of mitochondrial health,” Redox Biology, vol. 10, pp. 65–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. B. P. Dranka, G. A. Benavides, A. R. Diers et al., “Assessing bioenergetic function in response to oxidative stress by metabolic profiling,” Free Radical Biology & Medicine, vol. 51, no. 9, pp. 1621–1635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Desler, T. L. Hansen, J. B. Frederiksen, M. L. Marcker, K. K. Singh, and R. L. Juel, “Is there a link between mitochondrial reserve respiratory capacity and aging?” Journal of Aging Research, vol. 2012, Article ID 192503, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Ferrick, A. Neilson, and C. Beeson, “Advances in measuring cellular bioenergetics using extracellular flux,” Drug Discovery Today, vol. 13, no. 5-6, pp. 268–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. B. Jekabsons and D. G. Nicholls, “In situ respiration and bioenergetic status of mitochondria in primary cerebellar granule neuronal cultures exposed continuously to glutamate,” The Journal of Biological Chemistry, vol. 279, no. 31, pp. 32989–33000, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. L. Willard, B. Uberseder, A. Clark et al., “Long term sertraline effects on neural structures in depressed and nondepressed adult female nonhuman primates,” Neuropharmacology, vol. 99, pp. 369–378, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Styner, R. Knickmeyer, S. Joshi, C. Coe, S. J. Short, and J. Gilmore, Eds., Automatic Brain Segmentation in Rhesus Monkeys. Medical Imaging, International Society for Optics and Photonics, San Diego, CA, USA, 2007.
  46. J. A. Maldjian, C. A. Shively, M. A. Nader, D. P. Friedman, and C. T. Whitlow, “Multi-atlas library for eliminating normalization failures in non-human primatesNeuroinformatics,” vol. 14, no. 2, pp. 183–190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. M. S. Bharadwaj, D. J. Tyrrell, M. F. Lyles, J. L. Demons, G. W. Rogers, and A. J. Molina, “Preparation and respirometric assessment of mitochondria isolated from skeletal muscle tissue obtained by percutaneous needle biopsy,” Journal of Visualized Experiments, no. 96, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. G. W. Rogers, M. D. Brand, S. Petrosyan et al., “High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria,” PLoS One, vol. 6, no. 7, article e21746, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. P. J. Crouch, R. Blake, J. A. Duce et al., “Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1–42,” The Journal of Neuroscience, vol. 25, no. 3, pp. 672–679, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Wang, B. Su, H.-G. Lee et al., “Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease,” The Journal of Neuroscience, vol. 29, no. 28, pp. 9090–9103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Wang, B. Su, L. Zheng, G. Perry, M. A. Smith, and X. Zhu, “The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease,” Journal of Neurochemistry, vol. 109, pp. 153–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Wang, B. Su, S. L. Siedlak et al., “Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19318–19323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. X. Wang, B. Su, H. Fujioka, and X. Zhu, “Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer’s disease patients,” The American Journal of Pathology, vol. 173, no. 2, pp. 470–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Chen and D. C. Chan, “Mitochondrial dynamics – fusion, fission, movement, and mitophagy – in neurodegenerative diseases,” Human Molecular Genetics, vol. 18, no. R2, pp. R169–R176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Chen, J. M. McCaffery, and D. C. Chan, “Mitochondrial fusion protects against neurodegeneration in the cerebellum,” Cell, vol. 130, no. 3, pp. 548–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Narendra, A. Tanaka, D.-F. Suen, and R. J. Youle, “Parkin-induced mitophagy in the pathogenesis of Parkinson disease,” Autophagy, vol. 5, no. 5, pp. 706–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. T. Lin and M. F. Beal, “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases,” Nature, vol. 443, no. 7113, pp. 787–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. G. J. Tranah, J. S. Yokoyama, S. M. Katzman et al., “Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African Americans,” Neurobiology of Aging, vol. 35, no. 2, pp. 442.e1–442.e8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. P. G. Ridge, T. J. Maxwell, C. D. Corcoran et al., “Mitochondrial genomic analysis of late onset Alzheimer’s disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging,” PLoS One, vol. 7, no. 9, article e45134-e, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. P. G. Ridge, A. Koop, T. J. Maxwell et al., “Mitochondrial haplotypes associated with biomarkers for Alzheimer’s disease,” PLoS One, vol. 8, no. 9, article e74158-e, 2013. View at Publisher · View at Google Scholar
  61. A. Santoro, V. Balbi, E. Balducci et al., “Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer’s disease,” PLoS One, vol. 5, no. 8, article e12037-e, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. M. J. Keogh and P. F. Chinnery, “Mitochondrial DNA mutations in neurodegeneration,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1847, no. 11, pp. 1401–1411, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. L. M. Reynolds, J. Ding, J. R. Taylor et al., “Transcriptomic profiles of aging in purified human immune cells,” BMC Genomics, vol. 16, p. 333, 2015. View at Publisher · View at Google Scholar · View at Scopus